Simulations Plus’ (SLP) Outperform Rating Reiterated at William Blair

William Blair reiterated their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a research note issued to investors on Wednesday morning,RTT News reports. William Blair also issued estimates for Simulations Plus’ Q2 2025 earnings at $0.22 EPS, Q3 2025 earnings at $0.34 EPS, Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.09 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.32 EPS, Q3 2026 earnings at $0.44 EPS, Q4 2026 earnings at $0.43 EPS and FY2026 earnings at $1.35 EPS.

Several other equities research analysts also recently weighed in on SLP. BTIG Research lowered their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Finally, Stephens assumed coverage on Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $49.00.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP opened at $28.25 on Wednesday. The firm’s 50 day simple moving average is $29.82 and its 200-day simple moving average is $33.82. Simulations Plus has a one year low of $24.00 and a one year high of $51.22. The firm has a market cap of $567.40 million, a PE ratio of 57.65 and a beta of 0.80.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The firm had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. During the same quarter last year, the firm posted $0.18 earnings per share. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. Equities research analysts predict that Simulations Plus will post 1.1 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total value of $635,200.00. Following the completion of the sale, the director now owns 3,442,584 shares of the company’s stock, valued at approximately $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 19.40% of the stock is owned by company insiders.

Institutional Trading of Simulations Plus

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp raised its holdings in Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock valued at $20,503,000 after buying an additional 28,953 shares during the period. Geode Capital Management LLC increased its position in shares of Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock valued at $14,367,000 after acquiring an additional 18,924 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Simulations Plus by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after acquiring an additional 37,992 shares during the period. Tributary Capital Management LLC lifted its holdings in shares of Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after acquiring an additional 115,122 shares during the last quarter. Finally, Royce & Associates LP boosted its position in shares of Simulations Plus by 28.8% during the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock worth $7,602,000 after purchasing an additional 53,092 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.